The TAP complex influences allorecognition of class II MHC molecules

Human Immunology

Volumn 50, Issue 1, 1996, Pages 70-77

  Carmichael, Paul ^a   Kerr, Lesley Anne ^b   Kelly, Adrian ^b   Lombardi, Giovanna ^a   Zeigler, Barbara Uchanska ^c   Ziegler, Andreas ^c   Trowsdale, John ^b   Lechler, Robert ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030587502     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(96)00119-X     Document Type: Article

References (36)

1. 1. Morrison LA, Lukacher AE, Braciale VL, Fan DP, Braciale TJ: Differences in antigen presentation to MHC class I-and class II restricted influenza virus-specific cytolytic T lymphocyte clones. J Exp Med 163:903, 1986.
2. 2. Blum JS, Cresswell P: Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci USA 85:3975, 1988.
3. 3. Roche PA, Cresswell P: Invariant chain association with HLA-DR molecules inhibits immunogenic peptidebinding. Nature 45:615, 1990.
4. 4. Teyton L, O'Sullivan D, Dickson PW, Lotteau V, Sette A, Fink P, Peterson PA: Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348:39, 1990.
5. 5. Neefjes JJ, Stollorz V, Peters PJ, Greuze HJ, Ploegh HL: The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61:171, 1990.
6. 6. Townsend A, Ohlen C, Bastin J, Ljunggren H-G, Foster L, Karre K: Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443, 1989.
7. 7. Townsend A, Elliot T, Cerundolo V, Foster L, Barber B, Tse A: Assembly of MHC class I molecules analysed in vitro. Cell 62:285, 1990.
8. 8. Schumacher TNM, DeBruijn ML, Vernie LN, Kast WM, Melief CF, Neefjes JJ, Ploegh HL: Peptide selection by MHC class I molecules. Nature 350:703, 1996.
9. 9. Monaco JJ, Cho S, Attaya M: Transport protein genes in the murine MHC: possible implications for antigen processing. Science 250:1723, 1990.
10. 10. Deverson EV, Gow IR, Coadwell WJ, Monaco JJ, Butcher GW, Howard JC: MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 348:738, 1990.
11. 11. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A: Sequences encoded in the class II region of the MHC related to the ABC" superfamily of transporters. Nature 348:741, 1990.
12. 12. Spies T, Bresnshan M, Bahram S, Baham Armnold D, Blanck G, Mellins E, Pious D, DeMars R: A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348:744, 1990.
13. 13. Kelly A, Powis SH, Kerr LA, Mockridge T: Assembly and function of the two ABC transporter proteins encoded in the major histocompatibility complex. Nature 355:641, 1992.
14. 14. Spies T, Cerundolo V, Colonna M: Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355: 644, 1992.
15. 15. Jacobson S, Sekaly RP, Jacobsen CL, McFarlane HF, Long EO: HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol 63: 1756, 1989.
16. 16. Nuchtern JG, Biddison WE, Klausner RD: Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 343:74, 1990.
17. k. Nature 337:274, 1989.
18. 18. Malnati MS, Marti M, LaVaute T, Jarquemada D, Biddison W, DeMars R, Long EO: Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells Nature 357:702, 1992.
19. 19. Bijlmakers M-JJE, Benaroch P, Ploegh HL: Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J 13:2699, 1994.
20. 20. Volz A, Fonatsch C, Ziegler A: Regional mapping of the gene for autosomal dominant spinocerebellar ataxia (SCA10) by localising closely linked D6S89 locus to 6p24.2→p23.05. Cytogenet Cell Genet 60:37, 1992.
21. 21. Spring B, Fonatsch C, Mullet C, Pawlec G, Kompf J, Wernet P, Zeigler A: Refinement of HLA mapping with induced B-cell line mutants. Immunogenetics 21:277, 1985.
22. 22. Spies T, DeMars R: Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351:323, 1991.
23. 23. DeMars R, Chang CC, Shaw S, Reitnauer PJ, Sondel PM: Homozygous deletion that simultaneously eliminate expression of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Hum Immunol 11:77, 1984.
24. 24. Lombardi G, Sidhu S, Lamb JR, Batchelor JR, Lechler RI: Co-recognition of endogenous antigens with HLA-DR1 by alloreactive human T cell clones. J Immunol 142:753, 1989.
25. 25. Maddox JF, Bodmer JG: In Dupont B (ed). Immunobiology of HLA. Springer-Verlag, 1989, pp. 373-375.
26. 26. Pious D, Dixon L, Levine F, Cotner T, Johnson R: HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutations. J Exp Med 162:1193, 1985.
27. 27. Mellins E, Smith L, Arp BA, Cotner T, Celis E, Pious D: Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 343:71, 1990.
28. 28. Morris P, Shaman J, Attaya M, Amaya M, Goodman S, Bergman C, Monaco JJ, Mellins E: An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551, 1994.
29. 29. Fling SP, Arp B, Pious D: HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554, 1994.
30. 30. Eckels DD, Gorski J, Rothbard J, Lamb JR: Peptide-mediated modulation of T-cell allorecognition. Proc Natl Acad Sci USA 85:8191, 1988.
31. 31. Heath WR, Sherman LA: Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: a consequence of peptide-dependent allorecognition. Eur J Immunol 21:153, 1990.
32. 32. Rotzschke O, Falk K, Faath S, Rammensee HG: On the nature of peptides involved in T cell alloreactivity. J Exp Med 174:1059, 1991.
33. 33. Chicz RM, Urban RG, Gorga D, Stern J, Vignali AA, Lane S, Strominger JL: Predominantly naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764, 1992.
34. 34. Chicz RM, Urban RG, Gorga D, Vignali AA, Lane S, Strominger JL: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178:27, 1993.
35. 35. Kleijmeer M, Kelly A, Greuze HJ, Slot JW, Townsend A, Trowsdale J: Location of MHC-encoded transporters in the endoplasmic reticulum and cis-golgi. Nature 357: 342, 1992.
36. 36. Bodmer H, Viville S, Benoist C, Mathis D: Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 263:1284, 1994.